TransMedics (TMDX) Selling, General & Administrative (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.96 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -207.22 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 349.70 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 351.80 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn | 62.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.99 Mn |
| Dec 31, 2025 | 51.44 Mn |
| Sep 30, 2025 | 46.02 Mn |
| Jun 30, 2025 | 44.09 Mn |
| Mar 31, 2025 | 43.63 Mn |
| Dec 31, 2024 | 46.91 Mn |
| Sep 30, 2024 | 42.66 Mn |
| Jun 30, 2024 | 42.90 Mn |
| Mar 31, 2024 | 36.16 Mn |
| Dec 31, 2023 | 34.56 Mn |
| Sep 30, 2023 | 30.65 Mn |
| Jun 30, 2023 | 29.36 Mn |
| Mar 31, 2023 | 24.98 Mn |
| Dec 31, 2022 | 21.73 Mn |
| Sep 30, 2022 | 16.85 Mn |
| Jun 30, 2022 | 17.38 Mn |
| Mar 31, 2022 | 13.94 Mn |
| Dec 31, 2021 | 12.00 Mn |
| Sep 30, 2021 | 10.34 Mn |
| Jun 30, 2021 | 9.16 Mn |
| Mar 31, 2021 | 6.79 Mn |
| Dec 31, 2020 | 6.18 Mn |
| Sep 30, 2020 | 5.49 Mn |
| Jun 30, 2020 | 5.87 Mn |
| Mar 31, 2020 | 6.65 Mn |
| Dec 28, 2019 | 6.17 Mn |
| Sep 28, 2019 | 6.52 Mn |
| Jun 29, 2019 | 6.25 Mn |
| Mar 30, 2019 | 4.65 Mn |
| Dec 29, 2018 | 4.37 Mn |
| Sep 29, 2018 | 2.80 Mn |
| Jun 30, 2018 | 2.90 Mn |
| Mar 31, 2018 | 2.24 Mn |